Aussie Research Finds Schizophrenia Drugs Prevent Some Cancers
This article was originally published in PharmAsia News
Executive SummaryAustralian researchers suggest some drugs for treating schizophrenia also have the ability to treat certain types of cancer. The scientists found that people with schizophrenia had lower rates of cancer. The finding was particularly true relative to lung cancer although schizophrenics are considered more likely to smoke. The research suggests previous assertions that drugs such as pimozide taken to treat schizophrenia also inhibit the growth of cells responsible for lung, breast and brain cancer. (Click here for more
You may also be interested in...
Scrip’s on-the-ground team in Asia talks about how the regional and wider pharma industry and policymakers have responded so far to the spreading coronavirus outbreak, with a focus on the expedited development of potential drugs and vaccines.
Oncologic Drugs Advisory Committee votes 6-5 that ramucirumab’s benefit/risk profile is favorable in first-line lung cancer, but 13-2 that pivotal trial data do not support approval of Steba’s vascular-targeted, photodynamic therapy for low-risk prostate cancer.